Stock 4886 ASKA PHARMACEUTICAL HOLDINGS CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company ASKA Pharmaceutical Holdings Co.,Ltd.

Equities

4886

JP3119660003

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-02 EDT 		5-day change 1st Jan Change
2,267 JPY -1.18% Intraday chart for ASKA Pharmaceutical Holdings Co.,Ltd. +1.25% +27.07%
2023 Ha Tay Pharmaceutical JSC announced that it has received VND 180.6 billion in funding from ASKA Pharmaceutical Holdings Co.,Ltd. CI
2023 ASKA Pharmaceutical Holdings Co.,Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 CI

Business Summary

ASKA Pharmaceutical Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company mainly operates in two business segments. The Pharmaceutical segment is mainly engaged in the manufacture, purchase and sale of pharmaceutical products. The Others segment is involved in the manufacture of veterinary drugs, the provision of clinical testing services, the outsourcing of testing services, the purchase and sale of medical equipment, as well as the sale of health foods.

Number of employees: 747

Sales per Business

JPY in Million2022Weight2023Weight Delta
Pharmaceutical
88.6 %
50,791 89.7 % 53,579 88.6 % +5.49%
Animal Health
11.0 %
- - 6,660 11.0 % -
Others
0.4 %
5,816 10.3 % 220 0.4 % -96.22%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
100.0 %
56,607 100.0 % 60,461 100.0 % +6.81%

Managers

Managers TitleAgeSince
Takashi Yamaguchi PSD
 President 72 21-03-31
Kiyohiko Tamura ADM
 Chief Administrative Officer - -
Kunihiro Gunji CMP
 Compliance Officer - 21-03-31
Fumiyoshi Yamaguchi BRD
 Director/Board Member - -
Maiko Mori BRD
 Director/Board Member - -
Ikuo Kumano AUD
 Comptroller/Controller/Auditor 66 21-03-31
Yuichiro Fukui AUD
 Comptroller/Controller/Auditor 64 21-03-31

Members of the board

Members of the board TitleAgeSince
Takashi Yamaguchi PSD
 President 72 21-03-31
Atsushi Maruo BRD
 Director/Board Member 65 21-03-31
Yasunori Yoshimura BRD
 Director/Board Member 75 21-03-31
Yuichiro Fukui AUD
 Comptroller/Controller/Auditor 64 21-03-31
Sota Yamaguchi BRD
 Director/Board Member 40 21-03-31
Ikuo Kumano AUD
 Comptroller/Controller/Auditor 66 21-03-31
Maiko Mori BRD
 Director/Board Member - -
Fumiyoshi Yamaguchi BRD
 Director/Board Member - -
Minoru Awabayashi BRD
 Director/Board Member - 23-06-26
Koji Enokido BRD
 Director/Board Member - 23-06-26

Shareholders

NameEquities%Valuation
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD.
7.303 %
2,231,900 7.303 % 33 M ¥
TAKEDA PHARMACEUTICAL COMPANY LIMITED
7.211 %
2,204,000 7.211 % 32 M ¥
ZERIA PHARMACEUTICAL CO., LTD.
6.141 %
1,877,000 6.141 % 28 M ¥
NIPPON ACTIVE VALUE FUND PLC
4.861 %
1,485,600 4.861 % 22 M ¥
MITSUBISHI UFJ FINANCIAL GROUP, INC
3.599 %
1,100,000 3.599 % 16 M ¥
Takashi Yamaguchi
2.941 %
899,000 2.941 % 13 M ¥
Yamaguchi KK (Yokohama)
1.894 %
579,000 1.894 % 8 M ¥
Yamaguchi KK
1.894 %
579,000 1.894 % 8 M ¥
MS&AD INSURANCE GROUP HOLDINGS, INC.
1.734 %
530,000 1.734 % 8 M ¥
Nippon Life Insurance Co.
1.708 %
522,000 1.708 % 8 M ¥

Holdings

NameEquities%Valuation
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD.
7.30%
 2,231,900 7.30% 32,723,828 $
HA TAY PHARMACEUTICAL
22.36%
 18,411,178 22.36% 19,974,287 $
OSAKA SODA CO., LTD.
1.00%
 266,000 1.00% 16,978,163 $
MITSUBISHI UFJ FINANCIAL GROUP, INC
0.01%
 1,406,705 0.01% 14,471,829 $
INABATA & CO.,LTD.
1.08%
 606,000 1.08% 12,713,007 $
YAKULT HONSHA CO.,LTD.
0.11%
 360,000 0.11% 7,419,074 $
ZERIA PHARMACEUTICAL CO., LTD.
0.70%
 374,000 0.70% 5,268,545 $
YOKOGAWA BRIDGE HOLDINGS CORP.
0.54%
 235,000 0.54% 4,579,041 $
MITSUBISHI HC CAPITAL INC.
0.03%
 500,000 0.03% 3,534,970 $
KAGA ELECTRONICS CO.,LTD.
0.25%
 71,000 0.25% 2,993,029 $

Company contact information

ASKA Pharmaceutical Holdings Co., Ltd.

2-5-1 Shibaura Minato-Ku

108-8532, Tokyo

+

http://www.aska-pharma-hd.co.jp
address ASKA Pharmaceutical Holdings Co.,Ltd.(4886)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for ASKA Pharmaceutical Holdings Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2,267 JPY
Average target price
2,667 JPY
Spread / Average Target
+17.63%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD. Stock ASKA Pharmaceutical Holdings Co.,Ltd.
+27.07% 412M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+29.68% 699B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.07% 571B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.35% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.65% 326B
ABBVIE INC. Stock AbbVie Inc.
+3.77% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.68% 236B
NOVARTIS AG Stock Novartis AG
+4.71% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-12.43% 194B
PFIZER, INC. Stock Pfizer, Inc.
-3.82% 154B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4886 Stock
  4. Company ASKA Pharmaceutical Holdings Co.,Ltd.